Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'opioid' OR with Authors including 'opioid' OR with Abstract including 'opioid' OR with Keywords including 'opioid'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Martin WR The Nature of Opioid and LSD Receptors: Structural Activity Relationsh... QUASAR. Quantitative... 1978
Jasinski DR Interdisciplinary Studies on Phencyclidine at the Addiction Research C... Psychopharmacol.Bull... 1980
Jaffe JH, Kanzler M, Gree... Abuse potential of loperamide Clin Pharmacol Ther 1980
Ruffig DM, Domino EF Effects of Selected Opioid Agonists and Antagonists on DMT- and LSD-25... Psychopharmacology 1981
Domino EF, Ruffing DM Evidence for Opioids as Partial Antagonists for Indole Hallucinogens Psychopharmacology B... 1982
Shearman GT, Herz A Non-opioid Psychotomimetic-like Discriminative Stimulus Properties Of ... European Journal of ... 1982
Vaupel DB, Morton EC Anorexia and Hyperphagia Produced by Five Pharmacologic Classes of Hal... Pharmacology, Bioche... 1982
Arnerić SP, Maixner W, L... Structure-activity relationships of 2-aminotetralins and 2-aminoindane... Arch Int Pharmacodyn... 1982
Ruffing DM, Domino EF Interaction of Synthetic Opioid Metenkephalin Peptide Analogs, Lilly ... Psychopharmacology 1983
Mokler DJ, Commissaris R... Naloxone Alters the Effects of LSD, DOM and Quipazine on Operant Behav... Pharmacology Biochem... 1984
Knaus EE, Warren BK, Ondr... US Patent 4,468,403 : Analgesic Substituted Piperidylidine-2-sulfon(cy... USPTO 1984
Cheney BV, Szmuszkovicz J... Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzam... J Med Chem 1985
Pfeiffer A, Brantl V, Her... Psychotomimesis mediated by kappa opiate receptors. Science 1986
Gillman MA Nitrous oxide, an opioid addictive agent. Review of the evidence Am J Med 1986
Battaglia G, Brooks BP, K... Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... Eur J Pharmacol 1988
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Fujimoto RA, Boxer J, Jac... Synthesis, opioid receptor binding profile, and antinociceptive activi... J Med Chem 1989
Miczek KA, Tidey JW Amphetamines: aggressive and social behavior NIDA Res Monogr 1989
Bailey PL, Streisand JB, ... Differences in magnitude and duration of opioid-induced respiratory de... Anesth Analg 1990
Kosten TR Neurobiology of abused drugs. Opioids and stimulants J Nerv Ment Dis 1990
Bilsky EJ, Hubbell CL, De... MDMA produces a conditioned place preference and elicits ejaculation i... Pharmacol Biochem Be... 1991
Negri L, Erspamer GF, Sev... Dermorphin-related peptides from the skin of Phyllomedusa bicolor and ... Proc Natl Acad Sci U... 1992
Daly JW, Caceres J, Moni ... Frog secretions and hunting magic in the upper Amazon: identification ... Proc Natl Acad Sci U... 1992
Sosnowski M Pain management: physiopathology, future research and endpoints Support Care Cancer 1993
Stohler R, Rommelspacher ... [Beta-carbolines (harman/norharman) are increased in heroin dependent ... Ther Umsch 1993
Azolosa JL, Stitzer ML, G... Opioid physical dependence development: effects of single versus repea... Psychopharmacology (... 1994
Smith ML, Hughes RO, Levi... Forensic drug testing for opiates. VI. Urine testing for hydromorphone... J Anal Toxicol 1995
Reid LD, Hubbell CL, Tsai... Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... Pharmacol Biochem Be... 1995
Storrow AB, Magoon MR, No... The dextromethorphan defense: dextromethorphan and the opioid screen Acad Emerg Med 1995
Kintz P, Tracqui A, Mangi... Sweat testing in opioid users with a sweat patch J Anal Toxicol 1996
Reid LD, Hubbell CL, Tsai... Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... Pharmacol Biochem Be... 1996
Robson P, Bruce M A comparison of 'visible' and 'invisible' users of amphetamine, cocain... Addiction 1997
Uhl M Determination of drugs in hair using GC/MS/MS Forensic Sci Int 1997
Krupitsky EM, Grinenko AY Ketamine psychedelic therapy KPT: a review of the results of ten years... J Psychoactive Drugs 1997
Paronis CA, Woods JH Ventilation in morphine-maintained rhesus monkeys I: Effects of naltre... J Pharmacol Exp Ther 1997
Paronis CA, Woods JH Ventilation in morphine-maintained rhesus monkeys II: Tolerance to the... J Pharmacol Exp Ther 1997
Moore KA, Kilbane EM, Jon... Tissue distribution of ketamine in a mixed drug fatality J Forensic Sci 1997
Narcessian EJ, Yoon HJ False-positive urine drug screen: beware the poppy seed bagel J Pain Symptom Manag... 1997
Schmidt-Mutter C, Pain L,... The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus ma... Eur J Pharmacol 1998
Decker MW, Bannon AW, Buc... Antinociceptive effects of the novel neuronal nicotinic acetylcholine ... Eur J Pharmacol 1998
Gerak LR, Brandt MR, Fran... Studies on benzodiazepines and opioids administered alone and in combi... Psychopharmacology (... 1998
Thongpradichote S, Matsum... Identification of opioid receptor subtypes in antinociceptive actions ... Life Sci 1998
Essawi MY Fentanyl analogues with a modified propanamido group as potential affi... Pharmazie 1999
Yamamoto LT, Horie S, Tak... Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl... Gen Pharmacol 1999
McFee RB, Mofenson HC, Ca... Dextromethorphan: Another 'Ecstasy'? Arch Fam Med 2000
Erdtmann-Vourliotis M, Ma... Prior experience of morphine application alters the c-fos response to ... Brain Res Mol Brain ... 2000
Takayama H, Aimi N, Sakai... Chemical studies on the analgesic indole alkaloids from the traditiona... Yakugaku Zasshi 2000
Walsh SL, Strain EC, Abre... Enadoline, a selective kappa opioid agonist: comparison with butorphan... Psychopharmacology (... 2001
Walsh SL, Geter-Douglas B... Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pha... J Pharmacol Exp Ther 2001
Heinälä P, Alho H, Kiianm... Targeted use of naltrexone without prior detoxification in the treatme... J Clin Psychopharmac... 2001
Baumann MH, Pablo J, Ali ... Comparative neuropharmacology of ibogaine and its O-desmethyl metaboli... Alkaloids Chem Biol 2001
Roth BL, Baner K, Westkae... Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid... Proc Natl Acad Sci U... 2002
Latta KS, Ginsberg B, Bar... Meperidine: a critical review Am J Ther 2002
Takayama H, Ishikawa H, K... Studies on the synthesis and opioid agonistic activities of mitragynin... J Med Chem 2002
Tsuchiya S, Miyashita S, ... Effect of mitragynine, derived from Thai folk medicine, on gastric aci... Eur J Pharmacol 2002
Baker AK, Hoffmann VL, Me... Dextromethorphan and ketamine potentiate the antinociceptive effects o... Pharmacol Biochem Be... 2002
Benedetti F How the doctor's words affect the patient's brain Eval Health Prof 2002
Cone EJ, Fant RV, Rohay J... Oxycodone involvement in drug abuse deaths: a DAWN-based classificatio... J Anal Toxicol 2003
Sheffler DJ, Roth BL Salvinorin A: the 'magic mint' hallucinogen finds a molecular target i... Trends Pharmacol Sci 2003
Baker D, Pryce G, Giovann... The therapeutic potential of cannabis Lancet Neurol 2003
Vasconcelos SM, Rebouças... Antinociceptive activities of the hydroalcoholic extracts from Erythri... Biol Pharm Bull 2003
Drummer OH, Gerostamoulos... The incidence of drugs in drivers killed in Australian road traffic cr... Forensic Sci Int 2003
Compan V, Scearce-Levie K... Enkephalin contributes to the locomotor stimulating effects of 3,4-met... Eur J Neurosci 2003
Mowry M, Mosher M, Briner... Acute physiologic and chronic histologic changes in rats and mice expo... J Psychoactive Drugs 2003
Vecellio M, Schopper C, M... Neuropsychiatric consequences (atypical psychosis and complex-partial ... J Psychopharmacol 2003
Butelman ER, Harris TJ, K... The plant-derived hallucinogen, salvinorin A, produces kappa-opioid ag... Psychopharmacology (... 2003
Matsumoto K, Horie S, Ish... Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of a... Life Sci 2004
Chavkin C, Sud S, Jin W, ... Salvinorin A, an active component of the hallucinogenic sage salvia di... J Pharmacol Exp Ther 2004
Cone EJ, Fant RV, Rohay J... Oxycodone involvement in drug abuse deaths : II. Evidence for toxic mu... J Anal Toxicol 2004
Braida D, Iosue S, Pegori... Delta-9-Tetrahydrocannabinol-induced conditioned place preference and ... European Journal of ... 2004
Munro TA, Rizzacasa MA, R... Studies toward the pharmacophore of salvinorin A, a potent kappa opioi... J Med Chem 2005
Chen SL, Huang EY, Chow L... Dextromethorphan differentially affects opioid antinociception in rats Br J Pharmacol 2005
Lee DY, Karnati VV, He M,... Synthesis and in vitro pharmacological studies of new C(2) modified sa... Bioorg Med Chem Lett 2005
Lee DY, Ma Z, Liu-Chen LY... New neoclerodane diterpenoids isolated from the leaves of Salvia divin... Bioorg Med Chem 2005
Gillman PK Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity Br J Anaesth 2005
Schmidt MD, Schmidt MS, B... Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvin... Synapse 2005
Capasso R, Borrelli F, Ca... The hallucinogenic herb Salvia divinorum and its active ingredient sal... Neurogastroenterol M... 2006
Campos AR, Santos FA, Rao... Ketamine-induced potentiation of morphine analgesia in rat tail-flick ... Biol Pharm Bull 2006
Ott J Obviation of opioid withdrawal syndrome by concomitant administration ... J Psychoactive Drugs 2006
Ellgren M, Spano SM, Hurd... Adolescent Cannabis Exposure Alters Opiate Intake and Opioid Limbic Ne... Neuropsychopharmacol... 2006
Terner JM, de Wit H Menstrual cycle phase and responses to drugs of abuse in humans Drug Alcohol Depend 2006
Butelman ER, Mandau M, Ti... Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocr... J Pharmacol Exp Ther 2007
Rothman RB, Murphy DL, Xu... Salvinorin A: Allosteric Interactions at the {micro}-Opioid Receptor J Pharmacol Exp Ther 2007
Braida D, Limonta V, Pego... Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... Psychopharmacology (... 2007
Scheerer JR, Lawrence JF,... Asymmetric Synthesis of Salvinorin A, A Potent K Opioid Receptor Agoni... JACS 2007
Haney M Opioid Antagonism of Cannabinoid Effects: Differences between Marijuan... Neuropsychopharmacol... 2007
Mintzer IL, Eisenberg M, ... Treating opioid addiction with buprenorphine-naloxone in community-bas... Ann Fam Med 2007
Wager TD, Scott DJ, Zubie... Placebo effects on human {micro}-opioid activity during pain Proc Natl Acad Sci U... 2007
Panchal SJ, Müller-Schwef... Opioid-induced bowel dysfunction: prevalence, pathophysiology and burd... Int J Clin Pract 2007
Nocjar C, Panksepp J Prior morphine experience induces long-term increases in social intere... Behav Brain Res 2007
Alper KR, Lotsof HS, Kapl... The ibogaine medical subculture J Ethnopharmacol 2007
Grundmann O, Phipps SM, Z... Salvia divinorum and salvinorin A: an update on pharmacology and analy... Planta Med 2007
Chyka PA, Erdman AR, Mano... Dextromethorphan poisoning: an evidence-based consensus guideline for ... Clin Toxicol 2007
Boyer EW, Babu KM, Macali... Self-treatment of opioid withdrawal with a dietary supplement, Kratom Am J Addict 2007
Shields LB, Hunsaker Iii ... Methadone toxicity fatalities: a review of medical examiner cases in a... J Forensic Sci 2007
Munro TA, Duncan KK, Xu W... Standard protecting groups create potent and selective kappa opioids: ... Bioorg Med Chem 2008
Babu KM, McCurdy CR, Boye... Opioid receptors and legal highs: Salvia divinorum and Kratom Clin Toxicol (Phila) 2008
Farouk L, Laroubi A, Abou... Evaluation of the analgesic effect of alkaloid extract of Peganum harm... J Ethnopharmacol 2008
Hooker JM, Xu Y, Schiffer... Pharmacokinetics of the potent hallucinogen, salvinorin A in primates ... Neuroimage 2008
Wang Y, Chen Y, Xu W, Lee... 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist... J Pharmacol Exp Ther 2008

Page 1 of 3   /   246 Entries Returned
Pages:     
 1 
2 3 next